IndraLab

Statements


| 1

sparser
"We have found no evidence that common variations in RB1 , CDK2 , CDK4 , CDK6 , CDKN2A , CDKN2B , CDKN2C , CDKN2D , CCND1 , CCND3 , or CDKN1A are associated with outcome after a diagnosis of ovarian cancer."